ASCO Daily News

Latest Episodes:

Hematologic Cancer Highlights From ASCO26: MajesTEC-9, frontMIND, and More Jun 19, 2026

Show notes

Dr. Marc Braunstein and Dr. Adam Kittai highlight top research on hematologic malignancies from the 2026 ASCO Annual Meeting, including studies on lymphoid malignancies, multiple myeloma, and plasma cell disorders.

LINK TO FULL TRANSCRIPT

Lung Cancer Highlights From ASCO26: HARMONi-6, LIBRETTO-436, and More Jun 18, 2026

Show notes

Dr. Christine Lovly and Dr. Vamsi Velcheti discuss practice-changing lung cancer data presented at the 2026 ASCO Annual Meeting, including key studies on squamous cell lung cancer, NSCLC, and SCLC.

LINK TO FULL TRANSCRIPT

Day 5: Top Takeaways From ASCO26 Jun 02, 2026

Show notes

Dr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia in myelofibrosis, advances in RAS-mutated mCRC, novel therapies for AML, and a potentially practice-changing trial in TNBC.

LINK TO FULL TRANSCRIPT

Day 4: Top Takeaways From ASCO26 Jun 01, 2026

Show notes

Dr. Monty Pal shares highlights from Day 4 of the 2026 ASCO Annual Meeting, including a much-anticipated study in hepatocellular carcinoma, new data in non–small cell lung cancer, and a key update in the treatment of Merkel cell carcinoma.

LINK TO TRANSCRIPT

Day 3: Top Takeaways From ASCO26 May 31, 2026

Show notes

Dr. Monty Pal shares highlights from Day 3 of the 2026 ASCO Annual Meeting, including new research for the treatment of advanced CRC and mCRPC, TIL cell therapy in advanced non-uveal melanoma, and an ultra-low dose immunotherapy trial in head and neck squamous cell carcinoma.

LINK TO FULL TRANSCRIPT

Day 2: Top Takeaways From ASCO26 May 30, 2026

Show notes

Dr. Monty Pal shares highlights from Day 2 of the 2026 ASCO Annual Meeting, including a practice-changing trial in renal cell carcinoma, advances in ER-positive, HER2-negative early breast cancer, and the use of olanzapine as an effective steroid-sparing alternative for chemo-induced nausea and vomiting in pediatric cancer.

LINK TO FULL TRANSCRIPT

Day 1: Top Takeaways From ASCO26 May 29, 2026

Show notes

In the first episode of a special daily series during the 2026 ASCO Annual Meeting, Dr. Monty Pal discusses 3 abstracts, including a follow-up on the EV-302 study in urothelial carcinoma, a potential new treatment option for patients with PD-L1-positive advanced non–small cell lung cancer, and a novel psychosocial digital application that improves fatigue and distress in patients with multiple myeloma.

LINK TO FULL TRANSCRIPT

ASCO26 Preview: Novel Therapies and Innovations in Cancer Care May 21, 2026

Show notes

Dr. Monty Pal and Dr. Jo Chien preview new research, hot topics, and emerging innovations in oncology that will be presented at the 2026 ASCO Annual Meeting.

LINK TO FULL TRANSCRIPT

The Future of AI in Oncology: A Conversation With Google's AI Innovators May 14, 2026

Show notes

Google DeepMind's Dr. Alan Karthikesalingam and Google research scientist Anil Palepu sit down with Dr. Monty Pal to discuss the potential of Articulate Medical Intelligence Explorer (AMIE), a large language model-based experimental medical AI system designed to augment clinical decision-making in oncology and beyond, as well as the future of AI-human collaboration and how it could reshape health care over the next decade.

LINK TO FULL TRANSCRIPT

'No Margin for Error': What to Know Before Implementing AI in Clinical Practice Apr 16, 2026

Show notes

Dr. Monty Pal and Dr. Arturo Loaiza-Bonilla discuss the institutional risks in the use of artificial intelligence (AI) in clinical practice and how overreliance on AI could erode essential skills. They also highlight practical approaches, including routine "AI-off" drills, to help oncologists retain their decision-making agility.

LINK TO FULL TRANSCRIPT

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected